Results 81 to 90 of about 1,330 (141)

Perspective of using <i>in vitro</i> models to understand immunotherapy-induced cytokine release syndrome. [PDF]

Front Immunol
Perkins E, Cooper C, Lund E, Alb M, Morgan H, Fogal B, Hewitt P, Mazein A, Ostaszewski M, Sewald K.   +9 more
europepmc   +1 more source

The Role of Artificial Intelligence in Herpesvirus Detection, Transmission, and Predictive Modeling: With a Special Focus on Marek's Disease Virus. [PDF]

Pathogens
Akbar H.
europepmc   +1 more source

Evolution of <i>Toxoplasma gondii</i> Detection and Genotyping Methods. [PDF]

J Parasitol Res
Kowalczyk M, Sroka J, Wójcik-Fatla A.
europepmc   +1 more source

Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017-2019. [PDF]

J Infect Dis
Buchan SA, Alessandrini J, Drover SSM, Andrew MK, Bronskill SE, Brown KA, Daneman N, Deeks SL, Gubbay JB, Johnstone J, Karnauchow TM, Lee S, McGeer AJ, McNally JD, McNeil SA, Mubareka S, Murti M, Smieja M, Wilson SE, Kwong JC.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Marek's disease vaccines: A solution for today but a worry for tomorrow?

Vaccine, 2008
Marek's disease (MD) is a lymphoproliferative disease of chickens that, in the absence of control measures, is capable of causing devastating losses in commercial poultry flocks. MD has been successfully controlled by vaccination since 1968. However, vaccine efficacy has decreased concomitantly with the increase in virulence of Marek's disease virus ...
Isabel Gimeno
exaly   +3 more sources

The stability of reconstituted Marek's disease vaccines

Journal of Biological Standardization, 1977
A selection of commercial turkey herpesvirus (HVT) vaccines and a standard preparation THV/7 were reconstituted in various diluents and examined for stability. Results confirmed the suitability of a diluent containing sucrose, phosphate, glutamate and albumin (SPGA) as a diluent for HVT vaccines and also demonstrated the poor stability of vaccines ...
R A, Nicholas, D H, Thornton, C N, Hebert, J C, Muskett, C W, Evans   +4 more
openaire   +2 more sources

Field Trials of Vaccines for Marek's Disease

Avian Diseases, 1971
SUMMARY Seventeen field trials involving 391,202 birds were carried out in North Georgia to evaluate experimental vaccines for Marek's disease. Herpesvirus vaccines of both turkey and chicken origin were found to be "safe" with respect to their lack of any oncogenic ability in vaccinated birds. However, only the turkey herpesviruses (Georgia strain WHG
C S, Eidson, D P, Anderson, S H, Kleven, J, Brown   +3 more
openaire   +2 more sources

A study of vaccination against Marek's disease with an attenuated Marek's disease virus

Avian Pathology, 1974
Approximately 2,000 day-old white leghorn chickens were distributed into 10 pens and half the pens vaccinated with the attenuated strain of HPRS-16. At 72 weeks of age, mortality from non-specific death and Marek's disease was 17.6% and 15.6% respectively, in vaccinated chickens compared with 14.2% and 51.7% in unvaccinated chickens.
C A, Jackson, P M, Biggs, R A, Bell, F M, Lancaster, B S, Milne   +4 more
openaire   +2 more sources

Marek's disease vaccination of chickens

Australian Veterinary Journal, 1996
Interpretive summaries of interesting articles on veterinary pharmacology are provided by the Pharmacology Chapter of the Australian College of Veterinary ...
openaire   +4 more sources

Efficacy of a bivalent vaccine against Marek's disease

Research in Veterinary Science, 1987
A bivalent vaccine was prepared by combining inactivated Marek's disease virus and turkey herpesvirus. The efficacy of this vaccine, compared to turkey herpesvirus and inactivated Marek's disease virus separately, was studied in unsexed White Leghorn chicks which were vaccinated at one day old and then challenged at 21 days old with fowl blood infected
A K, Pruthi, R K, Gupta, J R, Sadana
openaire   +2 more sources